Seladin-1 expression is regulated by promoter methylation in adrenal cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Simi, Lisa ^a   Malentacchi, Francesca ^a   Luciani, Paola ^a   Gelmini, Stefania ^a   Deledda, Cristiana ^a   Arvia, Rosaria ^a   Mannelli, Massimo ^a   Peri, Alessandro ^a   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HORMONE RECEPTOR; MESSENGER RNA; SELADIN 1; UNCLASSIFIED DRUG; AZACITIDINE; DHCR24 PROTEIN, HUMAN; DNA METHYLTRANSFERASE; DRUG DERIVATIVE; ENZYME INHIBITOR; NERVE PROTEIN; OXIDOREDUCTASE;

ADRENAL CORTEX CARCINOMA; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA MODIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO CULTURE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN METHYLATION; ADRENAL TUMOR; CARCINOMA; DNA METHYLATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM; TIME; TUMOR CELL LINE;

ADRENAL GLAND NEOPLASMS; AZACITIDINE; CARCINOMA; CELL LINE, TUMOR; DNA METHYLATION; DNA MODIFICATION METHYLASES; ENZYME INHIBITORS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NERVE TISSUE PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TIME FACTORS;

EID: 77952039456     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-201     Document Type: Article

References (27)

1. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau BM, Nitsch R. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. Journal of Neurosciences 2000, 20:7345-7352.
2. Takahashi T, Gasch A, Nishizawa N, Chua NH. The DIMINUTO gene of Arabidopsis is involved in regulating cell elongation. Genes & Development 1995, 9:97-107.
3. Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puoliväli J, Salminen A, Helisalmi S, Soininen H. Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 2002, 113:301-310. 10.1016/S0306-4522(02)00180-X, 12127087.
4. Wu C, Miloslavskaya I, Demontis S, Maestro R, Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 2004, 432:640-645. 10.1038/nature03173, 15577914.
5. Freeman MR, Solomon KR. Cholesterol and prostate cancer. Journal of cellular Biochemistry 2004, 91:54-69. 10.1002/jcb.10724, 14689582.
6. Kolanjiappan K, Ramachandran CR, Manoharan S. Biochemical changes in tumor tissues of oral cancer patients. Clinical Biochemistry 2003, 36:61-65. 10.1016/S0009-9120(02)00421-6, 12554062.
7. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proceeding of the National Academy of Sciences of the United States of America 2001, 98:5856-5861.
8. Arispe N, Doh M. 2002 Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40.) and (1-42.) peptides. FASEB Journal 2001, 16:1526-1536.
9. Crameri A, Biondi E, Kuehnle K, Lutjohann D, Thelen KM, Perga S, Dotti CG, Nitsch RM, Ledesma MD, Mohajeri MH. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO Journal 2006, 25:432-443. 10.1038/sj.emboj.7600938, 1383521, 16407971.
10. Hartmann T, Kuchenbecker J, Grimm MO. Alzheimer's disease: the lipid connection. Journal of Neurochemistry 2007, 103:159-170. 10.1111/j.1471-4159.2007.04715.x, 17986151.
11. Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W. Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiology of Disease 2008, 29:422-437. 10.1016/j.nbd.2007.10.005, 2720683, 18086530.
12. Nelson PS. Identifying immunotherapeutic targets for prostate carcinoma through the analysis of gene expression profiles. Annals of the New York Academy of Sciences 2002, 975:232-246. 10.1111/j.1749-6632.2002.tb05955.x, 12538168.
13. Zhang H, Dong Y, Zhao H, Brooks JD, Hawthorn L, Nowak N, Marshall JR, Gao AC, Ip C. Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. Cancer Genomics and Proteomics 2005, 2:97-114. 2424238, 18548127.
14. Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Research 2006, 66:5012-5020. 10.1158/0008-5472.CAN-05-3082, 16707422.
15. Fuller PJ, Alexiadis M, Jobling T, McNeilage J. Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours. Clinical Endocrinology 2005, 63:111-115. 10.1111/j.1365-2265.2005.02308.x, 15963070.
16. Doherty SC, McKeown SR, Lopez JA, Walsh IK, McKelvey-Martin VJ. Gene expression in normal urothelium depends on location within the bladder: a possible link to bladder carcinogenesis. European Urology 2006, 50:290-301. 10.1016/j.eururo.2006.01.012, 16455181.
17. Nagai MA, Ros N, Bessa SA, Mourão Neto M, Miracca EC, Brentani MM. Differentially expressed genes and estrogen receptor status in breast cancer. International Journal of Oncology 2003, 23:1425-1430.
18. Di Stasi D, Vallacchi V, Campi V, Ranzani T, Daniotti M, Chiodini E, Fiorentini S, Greeve I, Prinetti A, Rivoltini L, Pierotti MA, Rodolfo M. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis. International Journal of Cancer 2005, 115:224-230.
19. Luciani P, Gelmini S, Ferrante E, Lania A, Benvenuti S, Baglioni S, Mantovani G, Cellai I, Ammannati F, Spada A, Serio M, Peri A. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. Journal of Clinical Endocrinology & Metabolism 2005, 90:6156-6161.
20. Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti S, Nesi G, Valeri A, Greve I, Serio M, Mannelli M, Peri A. Expression of the novel adrenocorticotropin-responsive gene Selective Alzheimer's Desease Indicator-1 in the normal adrenal cortex and in adrenal adenomas and carcinomas. Journal of Clinical Endocrinology & Metabolism 2004, 89:1332-1339.
21. Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H, Seo H. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas. Journal of Clinical Endocrinology & Metabolism 2001, 86:5130-5137.
22. Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T, Seo H. DHCR24 is a hydrogen peroxide scavenger, protecting cells from oxidative-stress-induced apoptosis. Endocrinology 2008, 149:3267-3273. 10.1210/en.2008-0024, 18339707.
23. Battista MC, Roberge C, Otis M, Gallo-Payet N. Seladin-1 expression in rat adrenal gland: effect of adrenocorticotropic hormone treatment. Journal of Endocrinology 2007, 192:53-66. 10.1677/joe.1.07062, 17210742.
24. Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical Cancer Research 2004, 10:7457-7465. 10.1158/1078-0432.CCR-04-0930, 15569975.
25. Kuehnle K, Crameri A, Kälin RE, Luciani P, Benvenuti S, Peri A, Ratti F, Rodolfo M, Kulic L, Heppner FL, Nitsch RM, Mohajeri MH. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Molecular and Cellular Biology 2008, 28:539-550. 10.1128/MCB.00584-07, 2223428, 17984220.
26. Gao Z-H, Suppola S, Liu J, Heikkila P, Janne J, Voutilanen R. Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. Journal of Clinical Endocrinology & Metabolism 2002, 87:1170-1176.
27. Liu J, Li X-D, Vaheri A, Voutilainen R. DNA methylation affects cell proliferation, cortisol secretion and steroidogenic gene expression in human adrenocorticaol NCI-H295R cells. Journal of Molecular Endocrinology 2004, 33:651-662. 10.1677/jme.1.01560, 15591025.